Clifton Park Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Clifton Park Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$12.3M	Sell	600,000 -155,156	-21%	-$2.97M	1.4%	12
2015 Q3	$12.9M	Sell	755,156 -294,844	-28%	-$5.39M	1.16%	12
2015 Q2	$19.6M	Hold	1,050,000	–	–	1.43%	12
2015 Q1	$20M	Sell	1,050,000 -234,100	-18%	-$4.33M	1.22%	14
2014 Q4	$21.1M	Sell	1,284,100 -115,900	-8%	-$1.99M	1.25%	15
2014 Q3	$24.8M	Hold	1,400,000	–	–	1.77%	14
2014 Q2	$28.9M	Hold	1,400,000	–	–	1.85%	13
2014 Q1	$30.5M	Hold	1,400,000	–	–	1.89%	15
2013 Q4	$37.1M	Sell	1,400,000 -181,987	-12%	-$4.47M	2.14%	15
2013 Q3	$37.4M	Hold	1,581,987	–	–	2.22%	18
2013 Q2	$34M	Buy	+1,581,987	New	+$34.1M	2.02%	18

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Clifton Park Capital Management's VIVO Position: Q4 2015 in Review

Clifton Park Capital Management reduced its Meridian Bioscience Inc (VIVO) stake by 21% in Q4 2015, selling an estimated $2.97M and leaving 600,000 shares worth $12.3M. The position accounts for 1.4% of the portfolio, ranked #12.

Clifton Park Capital Management first reported a position in VIVO in Q2 2013 and has held it in 11 quarters since. The position peaked at $37.4M in Q3 2013. 176 funds tracked by Wall St. Rank hold VIVO as of Q4 2015.

Clifton Park Capital Management held 600,000 shares of Meridian Bioscience Inc worth $12.3M as of Q4 2015.
Clifton Park Capital Management sold 155,156 Meridian Bioscience Inc shares in Q4 2015, an estimated $2.97M.
Meridian Bioscience Inc made up 1.4% of Clifton Park Capital Management's portfolio in Q4 2015, its #12 holding.
Clifton Park Capital Management first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 11 quarters since.
Clifton Park Capital Management's Meridian Bioscience Inc position peaked at $37.4M in Q3 2013.
176 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2015.

Based on Clifton Park Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.